Results 81 to 90 of about 711,937 (246)

Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.

JAMA Neurology, 2019
Importance Risk of developing progressive multifocal leukoencephalopathy (PML) is the major barrier to using natalizumab for patients with multiple sclerosis (MS). To date, the association of risk stratification with PML incidence has not been evaluated.
S. Vukusic, F. Rollot, R. Casey, J. Pique, R. Marignier, G. Mathey, G. Edan, D. Brassat, A. Ruet, J. de Sèze, E. Maillart, H. Zéphir, P. Labauge, N. Derache, C. Lebrun-Frénay, T. Moreau, S. Wiertlewski, E. Berger, X. Moisset, A. Rico-Lamy, B. Stankoff, C. Bensa, E. Thouvenot, O. Heinzlef, A. Al-Khedr, B. Bourre, M. Vaillant, P. Cabre, A. Montcuquet, A. Wahab, J. Camdessanche, A. Tourbah, A. Guennoc, K. Hankiewicz, I. Patry, C. Nifle, N. Maubeuge, C. Labeyrie, P. Vermersch, D. Laplaud   +39 more
semanticscholar   +1 more source

Treatment of progressive multifocal leukoencephalopathy [PDF]

QJM, 2013
Sir, I was very interested to read Pallin et al. ’s1 account of the management of an immunosuppressed patient with sarcoidosis …
openaire   +2 more sources

Gyriform Susceptibility Rim in Early Progressive Multifocal Leukoencephalopathy

Annals of Neurology, EarlyView.
Thor Linnet, Karan Dixit, Shailee Shah
wiley   +1 more source

Harnessing Natural Killer Cells: From Neuroimmunology to Novel Therapies for Central Nervous System Diseases

MedComm, Volume 7, Issue 10, October 2026.
This review delineates the multifaceted roles of natural killer (NK) cells in the central nervous system, spanning direct cytolysis, immunoregulation, and crosstalk with the brain microenvironment. We evaluate the translational potential and challenges of NK cell immunotherapies for a spectrum of neurological conditions.
Kaihang Deng, Wai Po Chong
wiley   +1 more source

Assessments of patients who developed natalizumab-related progressive multifocal leukoencephalopathy.

, 2016
Assessments of patients who developed natalizumab-related progressive multifocal leukoencephalopathy.
Nicola de Rossi (3595025), Lucia Moiola (3595028), Mirco Cosottini (431832), Simonetta Gerevini (3595022), Luca Prosperini (413158), Ruggero Capra (173333), Cristina Scarpazza (481651)   +6 more
core   +1 more source

Diagnosis and Management of Infectious Encephalitis in Adults: Guidelines From the European Academy of Neurology and European Society of Clinical Microbiology and Infectious Diseases

European Journal of Neurology, Volume 33, Issue 10, October 2026.
ABSTRACT Background Encephalitis is difficult to diagnose and manage, posing a challenge to clinicians. Since the last European guidelines were published in 2010, novel causes have emerged, diagnostic processes have evolved and treatments assessed which need to be reflected in updated guidelines.
Julia Granerod, Johann Sellner, Jean‐Paul Stahl, Sylviane Defres, Alexandra Mailles, Erich Schmutzhard, Elisabeth Aurelius, Thomas Whitfield, Luca Massacesi, Maarten J. Titulaer, Pille Taba, Benedict D. Michael, Tehmina Bharucha, Lance Turtle, Brendan Sargent, Arina Tamborska, Jonathan Cattrall, Yun Huang, Eva Maria Hodel, Suzannah Lant, Glynn Webb, Rajish S. K. Shil, Shalley Dhar, Diederik van de Beek, Marie Studahl, Matthijs C. Brouwer, Uta Meyding‐Lamade, Ava Easton, Bhagteshwar Singh, Tom Solomon   +29 more
wiley   +1 more source

Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM

Annals of Clinical and Translational Neurology, Volume 13, Issue 9, Page 1759-1771, September 2026.
ABSTRACT Objective PIGM encodes a critical enzyme in the glycosylphosphatidylinositol (GPI)‐anchor biosynthesis pathway. While promoter‐region mutations in PIGM have been associated with a relatively mild phenotype characterized by portal vein thrombosis and absence seizures, recent evidence suggests that coding‐region mutations result in a more severe
Júlia Sala‐Coromina, Anna Marcé‐Grau, Barbara Masotto, Marta Codina, Lamia BenJemaa, Yasmina Elaribi, Mónica Martinez‐Gallo, Roger Colobran, Angel Sanchez‐Montañez, Irene Valenzuela, Yoshiko Murakami, Alfons Macaya   +11 more
wiley   +1 more source

Progressive multifocal leukoencephalopathy (PML)

Rinsho Shinkeigaku, 2011
Progressive multifocal leukoencephalopathy (PML) is caused by reactivation of latently infected JCV when hosts' immune system is impaired by HIV infection, hematologic diseases, collagen diseases, immunemodulatory therapy and so on. PML was rare but HIV infection and Natalizumab have made it much more common while the prognosis is much better than ...
Mizusawa, Hidehiro, Kishida, Shuji, Saijo, Masayuki, Yukishita, Motohiro, Shishido-Hara, Yukiko, Sawa, Hirohumi, Nagashima, Kazuo, Nukuzuma, Souichi, Yamada, Masahito   +8 more
openaire   +3 more sources

Adult‐onset CD8‐predominant hemispheric inflammatory epilepsy: Expanding the spectrum of post‐infectious and Rasmussen‐like encephalitis

Epileptic Disorders, EarlyView.
Ramya Raghupathi
wiley   +1 more source

Tacrolimus‐Induced Atypical Posterior Reversible Encephalopathy Syndrome (PRES) in a Kidney Transplant Recipient: A Case Report

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT We report a 36‐year‐old woman who presented with acute visual hallucinations, delusions, and dizziness 2 months after uncomplicated kidney transplantation. Brain magnetic resonance imaging (MRI) revealed T2/FLAIR hyperintensities in the dorsal pons and bilateral temporal cortices, atypical yet consistent with PRES.
Roya Sadeghnia, Sayed Mortaza Fayez, Sara Samadi   +2 more
wiley   +1 more source